Billiontoone (NASDAQ:BLLN) Stock: Insider Bosch John Roderick Ten Sells 2,834 Shares

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 2,834 shares of Billiontoone stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $113.17, for a total value of $320,723.78. Following the sale, the senior vice president owned 16,551 shares in the company, valued at $1,873,076.67. The trade was a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Monday, October 5th, Bosch John Roderick Ten sold 2,834 shares of Billiontoone stock. The stock was sold at an average price of $105.15, for a total transaction of $297,995.10.
• On Thursday, September 24th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00.
• On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $106.61, for a total transaction of $150,959.76.
• On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $97.54, for a total transaction of $138,116.64.
• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $131,582.62.

Billiontoone Stock Down 1.3%

BLLN opened at $112.39 on Friday. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The stock has a market cap of $5.30 billion and a price-to-earnings ratio of 122.16. Billiontoone, Inc. has a twelve month low of $61.96 and a twelve month high of $150.44. The company’s 50-day moving average price is $104.99 and its two-hundred day moving average price is $97.01.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 10.95% and a return on equity of 9.42%. The firm had revenue of $109.45 million during the quarter. As a group, equities analysts expect that Billiontoone, Inc. will post 0.80 earnings per share for the current year.

Trending Headlines about Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q3 beat estimates: Revenue was about $123 million, above the roughly $115.8 million forecast, and reported earnings per share exceeded the $0.16 consensus. Q3 results and guidance
• Positive Sentiment: Higher outlook and product launch: BillionToOne raised its 2026 revenue guidance to $460 million–$470 million and said it plans to launch Northstar Clear on December 15. The higher forecast and upcoming product could support growth expectations. Revenue outlook and product launch
• Positive Sentiment: Analysts remain bullish: JPMorgan raised its price target to $135 and kept an Overweight rating; BTIG reaffirmed Buy with a $130 target. JPMorgan rating
• Negative Sentiment: Insider selling may weigh on sentiment: The CEO, CTO and an SVP sold shares. The reported transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen—but not remove—investor concern. Insider transaction details

Institutional Trading of Billiontoone

A number of institutional investors have recently modified their holdings of BLLN. Sei Investments Co. purchased a new stake in shares of Billiontoone during the first quarter worth $1,058,000. The Manufacturers Life Insurance Company boosted its holdings in shares of Billiontoone by 151.8% in the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock worth $2,408,000 after acquiring an additional 18,389 shares during the period. Wasatch Advisors LP boosted its holdings in shares of Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after acquiring an additional 148,446 shares during the period. Bank of America Corp DE grew its position in shares of Billiontoone by 8,603.4% in the first quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock valued at $1,003,000 after purchasing an additional 12,561 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust grew its position in shares of Billiontoone by 11.9% in the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock valued at $10,436,000 after purchasing an additional 14,072 shares in the last quarter.

Wall Street Analyst Weigh In

BLLN has been the topic of several research analyst reports. Guggenheim upped their price objective on Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Weiss Ratings downgraded Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, October 8th. JPMorgan Chase & Co. boosted their target price on Billiontoone from $130.00 to $135.00 and gave the company an “overweight” rating in a research note on Thursday. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, BTIG Research reaffirmed a “buy” rating and set a $130.00 price target on shares of Billiontoone in a research report on Thursday. Seven research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Billiontoone presently has an average rating of “Moderate Buy” and a consensus price target of $126.88.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.